Erick Wang practices corporate law, where he focuses primarily on mergers and acquisitions and securities law matters. His practice has included a broad and varied representation of public and private corporations and other entities in a variety of industries throughout the United States and abroad in connection with mergers and acquisitions, public and private equity offerings, joint ventures and other financing-related transactions. Erick has extensive experience representing energy, biotechnology, oil services, technology companies and, in particular, foreign companies in cross-border transactions and other international transactions.

Erick received his J.D. from Vanderbilt University Law School. While in law school, he received a Law & Business Certificate from the Vanderbilt Owen School of Management, and was also a recipient of the Vanderbilt Scholastic Excellence Award for overall best performance in Securities Regulation. He also served as a judicial extern to The Honorable Justo Arenas (Ret.), U.S. District Court for the District of Puerto Rico.

Bar Admissions
Texas

Education
J.D., Vanderbilt University Law School, 2007, Dean’s Scholar
B.A., Political Science, University of California, Los Angeles, 2002, cum laude

Significant Accomplishments
NYSE-listed oil and gas exploration company in its $1.5 billion acquisition of upstream oil and gas assets encompassing approximately 161,000 net acres in the Bakken formation.
NYSE-listed holding company in its divestiture of its $805 million upstream oil and gas assets to a private equity company.
Ongoing representation of the largest oilfield services and equipment company in China (non-SOE) in various matters in the United States.
Major international accounting firm in its acquisition of the Texas operations of another international accounting firm.
NYSE-listed oil and gas exploration company in its $333 million sale of upstream oil and gas assets in North Dakota to a private equity company.
Chinese oilfield services company in connection with various supply and distribution agreements with its U.S. customers.
NYSE-listed holding company in its proposed $800 million sale of upstream oil and gas assets encompassing approximately 1.1 million gross acres in Texas and Oklahoma to a private equity company.
Oil and gas exploration company in its $720 million sale of upstream oil and gas assets to a Chinese private equity company.
Chinese private equity company in its acquisition of upstream oil and gas assets in Louisiana.
Major French electric utility company in the sale of its U.S. crude oil acquisition and marketing business.
Technology company in its initial public offering of $41 million in equity and its follow-on public offering of US$83 million in equity on the Nasdaq Global Market.
New Zealand-based private equity fund in connection with its $650 million investment in an equity joint venture to construct and operate a methanol facility in Louisiana.
NYSE-listed Chinese biotech company in its proposed acquisition of a genetics business in Texas.
Latin American energy company in its proposed $10 billion joint venture with an oil and gas exploration company.
NYSE-listed midstream company in its acquisition of a storage and distribution terminal.
NYSE-listed energy company in its $2.5 billion sale of its refinery assets in California.
Hong Kong trading company in its proposed $1.4 billion acquisition of a major international fuel terminal in Texas.
Private equity fund in connection with the sale and purchase of upstream oil and gas assets up to $100 million each, including the engagement of anagement teams to operate the assets.
Anglo-Russian joint venture in its $1 billion farmout of a 45 percent participating interest in blocks located in the Solimoes Basin, onshore Brazil.
Private equity fund in connection with the sale and purchase of downstream oil and gas assets up to $75 million each.
NYSE-listed SPAC in its $150 million acquisition of an upstream oil and gas company.
Energy company in its $250 million acquisition of oil and gas assets located in Alberta, Canada.
UK company in its $150 million sale of its hydraulic accumulator business to a NYSE-listed company.
Health services company in its acquisition of a publicly-traded company through a $200 million reverse merger.
Ongoing representation of a NYSE-listed Chinese biotech company in mergers and acquisition in the United States up to $20 million each.
NYSE-listed Chinese biotech company in its $160 million acquisition of a U.S. company.
NYSE-listed waste management company in its $40 million acquisition of waste recycling facilities and assets.
NYSE-listed waste management company in its $38 million acquisition of landfill gas operations and assets.
Chinese manufacturer of oil country tubular goods in its $300 million joint venture with a U.S. company in the oil service industry.
Taiwan carbon black company in its $20 million acquisition of carbon-nanotube operations and assets, including the acquisition of significant intellectual property portfolios held by major universities.
Special committee of a major pipeline company in its $200 million exchange of various pipeline assets as part of a $1 billion pipeline build-out.